Premium
A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry
Author(s) -
Quintela Oscar,
Cruz Angelines,
Concheiro Marta,
Castro Ana de,
LópezRivadulla Manuel
Publication year - 2004
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.1719
Subject(s) - chemistry , chromatography , electrospray ionization , mass spectrometry , electrospray , formic acid , saliva , calibration curve , midazolam , detection limit , sample preparation , medicine , biochemistry , sedation , pharmacology
A rapid, sensitive and selective liquid chromatography/electrospray mass spectrometry (LC/ES‐MS) method was developed for the quantitative determination of the anaesthetic benzodiazepine midazolam (MID) in human saliva and plasma from patients undergoing anesthesia procedures. Biological samples spiked with diazepam‐ d 5 , the internal standard, were extracted into diethyl ether. Compounds were separated on a Xterra® RP 18 column using a mobile phase of acetonitrile/formic acid 0.1% at a flow rate of 0.25 mL/min under a linear gradient. Column effluents were analyzed using MS with an ES source in the positive ionization mode. Calibration curves were linear in the concentration ranges of 1–250 and 0.2–25 ng/mL in plasma and saliva, respectively. The limits of detection were 0.5 ng/mL in plasma and 0.1 ng/mL in saliva, using a 0.5‐mL sample volume. The recoveries of the spiked samples were above 65%. The method was applied to ten real samples from patients undergoing midazolam treatment. Copyright © 2004 John Wiley & Sons, Ltd.